ActiPatch Muscle and Joint Pain Therapy Device

Product Information

Rawe IM, Kotak DC. A UK registry study of the effectiveness of a new over-the-counter chronic pain therapy. Pain Manag. 2015;5(6):413-423. doi: 10.2217/PMT.15.35. Epub 2015 Aug 3. PMID: 26235410. The complete details on the award winners are available in the 2013 OTC Awards Supplement http://www.otc-bulletin.com/awards/pdfs/WinnersSupplement2013.pdf. ActiPatch Canada Commercial ActiPatch works by sending out electromagnetic signal pulses into the area where you experience pain. It sends out 1,000 pulses every second, stimulating the neuromodulation of your nerves dampening the feeling of pain with every pulse. It does all this without creating any feeling of vibration, heat, or any other uncomfortable sensation which you may experience with other drug-free pain relief.

International Association for the Study of Pain. IASP Revises Its Definition of Pain for the First Time Since 1979. Accessed: 26 February 2023. Available from: https://www.iasp-pain.org/wp-content/uploads/2022/04/revised-definition-flysheet_R2.pdf He said: "She’d never heard of it. I explained how it worked for me but she was unable to prescribe it for me as the request to the CCG was refused on the basis of there being ‘no evidence’ to support the benefits. Full prior agreement about patient’s on-going care must be reached under the shared care agreement. The OTC Bulletin, the leading global trade publication for over-the-counter healthcare products has chosen its ActiPatch® Musculoskeletal Pain Relief Therapy as the first runner-up for the “ Most Innovative New OTC Product.” Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances such as specialist GP.BioElectronics’ Smart Insole rides the wave of wearable tech’ that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem.” ActiPatch is drug-free and therefore should not have any side effects when used as recommended by the manufacturer. However, if you do experience any side effects while using this product, you should speak to your doctor or Chemist 4 U pharmacist right away. For more information about reporting the side effects of treatments, please see the MHRA’s Yellow Card Scheme. Primary care prescribers must be familiar with the drug to take on prescribing responsibility or must get the required information.

PSWT with ActiPatch appears to be a safe and reasonably effective modality for treating certain types of chronic pain. There are no absolute contraindications to its use and can be safely used with any ongoing pain medication. The device does not lead to adverse effects, which is encountered with pharmacotherapy. Further studies might explore its role in managing chronic pain syndromes of varying etiology and would enlighten clinicians with its safety and efficacy.Financial support and sponsorship Actipatch is a therapy device which can help you to manage pain in your muscles and joints. It’s completely medication-free, working wherever you place it on the body to ease pain and inflammation without creating any uncomfortable heat or vibrations. If you suffer from chronic pain and are looking for long-term relief, ActiPatch could be the perfect solution for you.Last month, the Royal College of General Practitioners announced that GPs did not want to prescribe them for long-term use. An spokesperson said: “Ultimately these are decisions for local GPs who rightly advise patients on their care, and have to decide how best to balance the various competing demands on the NHS.” I do not want to return to higher levels of medication. And I’m still trying to wean myself off of the remaining prescribed medications too.” Actipatch uses electromagnetic pulses to stimulate the neuromodulation of nerves, which helps to dampen the feeling of pain — without any feeling of vibration, heat, or other uncomfortable sensations. He added: “Failure to get a grip of the amount of opioids we are prescribing could see the UK replicate the chronic addiction problems they are currently experiencing in the US.